Price$36.47+1.30 (+3.70%)
2026-04-212026-07-24
News · 26 weeks29-88%
2026-02-012026-07-26
Mix2190d
- Insider14(67%)
- SEC Filings5(24%)
- Other2(10%)
Latest news
25 items- SECSEC Form DEFA14A filed by Kewaunee Scientific CorporationDEFA14A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- SECSEC Form DEF 14A filed by Kewaunee Scientific CorporationDEF 14A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- INSIDERSVP, People & Culture Phillips Elizabeth D converted options into 6,656 shares, returned $181,069 worth of shares to the company (4,995 units at $36.25) and covered exercise/tax liability with 793 shares, increasing direct ownership by 11% to 9,116 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSVP, IT & Engineering Ranade Mandar converted options into 7,227 shares, returned $65,250 worth of shares to the company (1,800 units at $36.25) and covered exercise/tax liability with 1,877 shares, increasing direct ownership by 28% to 16,215 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSVP, Sales & Marketing Dev Noble Ryan S. returned $108,750 worth of shares to the company (3,000 units at $36.25), covered exercise/tax liability with 1,809 shares and converted options into 7,206 shares, increasing direct ownership by 17% to 16,240 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSVP, Manufacturing Operations Batdorff Douglas J. converted options into 7,451 shares, returned $203,326 worth of shares to the company (5,609 units at $36.25) and covered exercise/tax liability with 851 shares, increasing direct ownership by 14% to 8,170 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERChief Financial Officer Gardner Donald T. Iii converted options into 21,265 shares, returned $435,000 worth of shares to the company (12,000 units at $36.25) and covered exercise/tax liability with 4,027 shares, increasing direct ownership by 55% to 14,802 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERPresident & CEO Hull Thomas David Iii converted options into 54,388 shares, returned $616,250 worth of shares to the company (17,000 units at $36.25) and covered exercise/tax liability with 16,243 shares, increasing direct ownership by 64% to 54,145 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- SECSEC Form 10-K filed by Kewaunee Scientific Corporation10-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- INSIDERSEC Form 4 filed by SVP, People & Culture Phillips Elizabeth D4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by SVP, IT & Engineering Ranade Mandar4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by SVP, Sales & Marketing Dev Noble Ryan S.4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by SVP, Manufacturing Operations Batdorff Douglas J.4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Gardner Donald T. Iii4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERSEC Form 4 filed by President & CEO Hull Thomas David Iii4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific Reports Results for Fiscal Year and Fourth QuarterSTATESVILLE, N.C., June 23, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its fiscal year and fourth quarter ended April 30, 2026. Fiscal Year 2026 Full Year ResultsFiscal year 2026 was highlighted by strong revenue, continued progress integrating Nu Aire, and significant balance sheet improvement, despite a challenging operating environment.Sales during fiscal year 2026 were $281,999,000, an increase of 17.3% compared to sales of $240,472,000 from the prior year. Pre-tax earnings for the fiscal year were $13,733,000 compared to p
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific to Report Results for Fiscal Year and Fourth QuarterSTATESVILLE, N.C., June 10, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2026 on Tuesday, June 23, 2026 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casew
- INSIDERDirector Gehl Keith M was granted 2,013 shares, increasing direct ownership by 10% to 22,409 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERDirector Campbell John Jette was granted 2,013 shares, increasing direct ownership by 292% to 2,703 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- PRKewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products GroupSTATESVILLE, N.C., April 14, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced the appointment of Jorge Santos as VP – International Sales – Lab Products Group, further strengthening the Company's commercial leadership as it accelerates growth in key global markets. Santos joins Kewaunee as the newest member of the Company's leadership team and will report directly to President and Chief Executive Officer, Thomas D. Hull III. "Jorge's appointment marks a significant step forward in Kewaunee's growth strategy outside of the North American market,"
- INSIDERSEC Form 4 filed by Pyle Margaret B4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- SECSEC Form 10-Q filed by Kewaunee Scientific Corporation10-Q - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
KEQU FAQ
5 questionsWhat does Kewaunee Scientific Corporation do?
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the...Where does KEQU stock trade?
Kewaunee Scientific Corporation (KEQU) is listed on NASDAQ.What sector and industry is KEQU in?
Kewaunee Scientific Corporation operates in the Industrials sector, Medical Specialities industry.What companies are similar to KEQU?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare KEQU side-by-side with any of them on Quantisnow.How can I track KEQU on Quantisnow?
Quantisnow aggregates Kewaunee Scientific Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KEQU to receive live email and push alerts on every new disclosure.